Recombinant multi-species ST3GAL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ST3GAL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the glycosyltransferase 29 family, a group of enzymes involved in protein glycosylation. The encoded protein is targeted to Golgi membranes but may be proteolytically processed and secreted. The gene product may also be involved in the increased expression of sialyl Lewis X antigen seen in inflammatory responses. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
The Alternative Names of target: 3-GalNAc-alpha-2,3-ST 4,3-sialyltransferase,3-sialyltransferase 4,3-sialyltransferase IV,4-GlcNAc-alpha-2,Alpha 2,Beta-galactoside alpha-2,CGS23,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,Gal-NAc6S,Gal-beta-1,N-acetyllactosaminide alpha-2,NANTA3,SAT-3,SAT3,SIAT4,SIAT4-C,SIAT4C,ST-4,ST3GAL-IV,ST3GAL4,ST3Gal IV,ST3Gal IV (ST3GalIV),ST3GalA.2,ST3GalIV,STZ,Sialyltransferase 4C (SIAT4-C),Siat4c,St3gal4,gal-NAc6S,siat4c

Target products collectionGo to ST3GAL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0489-Ag-1/ GM-Tg-hg-SE0489-Ag-2 Human ST3GAL4 protein Human
GM-Tg-rg-SE0489-Ag-1/ GM-Tg-rg-SE0489-Ag-2 Rat ST3GAL4 protein Rat
GM-Tg-mg-SE0489-Ag-1/ GM-Tg-mg-SE0489-Ag-2 Mouse ST3GAL4 protein Mouse
GM-Tg-cynog-SE0489-Ag-1/ GM-Tg-cynog-SE0489-Ag-2 Cynomolgus/Rhesus macaque ST3GAL4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0489-Ag-1/ GM-Tg-felg-SE0489-Ag-2 Feline ST3GAL4 protein Feline
GM-Tg-cang-SE0489-Ag-1/ GM-Tg-cang-SE0489-Ag-2 Canine ST3GAL4 protein Canine
GM-Tg-bovg-SE0489-Ag-1/ GM-Tg-bovg-SE0489-Ag-2 Bovine ST3GAL4 protein Bovine
GM-Tg-equg-SE0489-Ag-1/ GM-Tg-equg-SE0489-Ag-2 Equine ST3GAL4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0489-Ag-1/ GM-Tg-hg-SE0489-Ag-2; GM-Tg-rg-SE0489-Ag-1/ GM-Tg-rg-SE0489-Ag-2;
GM-Tg-mg-SE0489-Ag-1/ GM-Tg-mg-SE0489-Ag-2; GM-Tg-cynog-SE0489-Ag-1/ GM-Tg-cynog-SE0489-Ag-2;
GM-Tg-felg-SE0489-Ag-1/ GM-Tg-felg-SE0489-Ag-2; GM-Tg-cang-SE0489-Ag-1/ GM-Tg-cang-SE0489-Ag-2;
GM-Tg-bovg-SE0489-Ag-1/ GM-Tg-bovg-SE0489-Ag-2; GM-Tg-equg-SE0489-Ag-1/ GM-Tg-equg-SE0489-Ag-2
Products Name ST3GAL4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ST3GAL4
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ST3GAL4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.